Literature DB >> 20798945

[The current TNM system for gastrointestinal tumors part II].

A Tannapfel1, C Wittekind.   

Abstract

Entirely new classifications are those for gastrointestinal stromal tumours, gastrointestinal neuroendocrine tumours, intrahepatic cholangiocarcinoma and perihilar extrahepatic bile duct carcinomas. Major and praxis-relevant alterations concern colorectal tumours and include new classifications of carcinomas and carcinoids of the appendix. Minor alterations are seen in the classification of hepatocellular carcinomas. No changes were made for tumours of the anal canal, the gallbladder (excluding the inclusion of tumours of the cystic duct) and tumours of the pancreas and the ampulla of Vater.

Entities:  

Mesh:

Year:  2010        PMID: 20798945     DOI: 10.1007/s00292-010-1305-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  6 in total

1.  The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement.

Authors:  Günter Klöppel; Guido Rindi; Aurel Perren; Paul Komminoth; David S Klimstra
Journal:  Virchows Arch       Date:  2010-04-27       Impact factor: 4.064

2.  TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; A Couvelard; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

3.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

4.  Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

Authors:  Markku Miettinen; Hala Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

5.  Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.

Authors:  Ulrich-Frank Pape; Henning Jann; Jacqueline Müller-Nordhorn; Angelina Bockelbrink; Uta Berndt; Stefan N Willich; Martin Koch; Christoph Röcken; Guido Rindi; Bertram Wiedenmann
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

6.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

  6 in total
  2 in total

1.  Back to the start: Evaluation of prognostic markers in gastrointestinal stromal tumors.

Authors:  Eckhard Klieser; Maximilian Pichelstorfer; Denis Weyland; Ralf Kemmerling; Stefan Swierczynski; Adam Dinnewitzer; Tarkan Jäger; Tobias Kiesslich; Daniel Neureiter; Romana Illig
Journal:  Mol Clin Oncol       Date:  2016-03-11

2.  Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors.

Authors:  Ralf Kemmerling; Denis Weyland; Tobias Kiesslich; Romana Illig; Eckhard Klieser; Tarkan Jäger; Otto Dietze; Daniel Neureiter
Journal:  Oncol Lett       Date:  2014-01-15       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.